Calcitriol (RO215535)

For research use only.

Catalog No.S1466 Synonyms: Topitriol, 1,25-Dihydroxyvitamin D3

35 publications

Calcitriol (RO215535) Chemical Structure

CAS No. 32222-06-3

Calcitriol (RO215535, Topitriol, 1,25-Dihydroxyvitamin D3) is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol. Solutions are best fresh-prepared.

Selleck's Calcitriol (RO215535) has been cited by 35 publications

Purity & Quality Control

Choose Selective Vitamin Inhibitors

Biological Activity

Description Calcitriol (RO215535, Topitriol, 1,25-Dihydroxyvitamin D3) is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol. Solutions are best fresh-prepared.
Targets
vitamin D receptor [1]
(Cell-free assay)
In vitro

Calcitriol is a potent inhibitor of PHA-induced lymphocyte proliferation, achieving 70% inhibition of tritiated thymidine incorporation after 72 h in culture. Calcitriol suppresses interleukin-2 (IL-2) production by PHA-stimulated peripheral blood mononuclear cells in a concentration-dependent fashion. [1] Calcitriol increases the concentration of intracellular calcium ([Ca2+]i) within 5 s by mobilizing calcium from the endoplasmic reticulum and the formation of inositol 1,4, 5-trisphosphate and diacylglycerol. [2] Calcitriol can inhibit the proliferation and promote the differentiation of human prostate adenocarcinoma cells. Calcitriol causes a selective decrease in the secreted levels of type IV collagenases (MMP-2 and MMP-9). [3] Calcitriol has antiproliferative activity in squamous cell carcinoma and prostatic adenocarcinoma and enhances the antitumor activity of platinum-based agents. Calcitriol prior to paclitaxel significantly reduces clonogenic survival compared with either agent alone in the murine squamous cell carcinoma and PC-3 cells. [4] Calcitriol is a potent anti-proliferative agent in a wide variety of malignant cell types. Calcitriol effects are associated with an increase in G0/G1 arrest, induction of apoptosis and differentiation, modulation of expression of growth factor receptors. Calcitriol potentiates the antitumor effects of many cytotoxic agents and inhibits motility and invasiveness of tumor cells and formation of new blood vessels. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human HCT116 MYPDfZRwfG:6aXRCpIF{e2G7 Mo\RNVIxKGh? NUPlVZpRS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUEOWMUG2JIF{e2W|c3XkJIF{KGSnY4LlZZNmKGmwIHPlcIwh[2:3boSgZYZ1\XJiMUKwJIhzeyxiSVO1NF0y\S1yNTFOwG0> NIHrUYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkmyOlA3QCd-MkK5NlYxPjh:L3G+
HOS MWPGeY5kfGmxbjDhd5NigQ>? MnHKRYN1cX[rdImgZZQhcHWvYX6gWmRTKGW6cILld5Nm\CCrbjDoeY1idiCKT2OgZ4VtdHNidILhcpNn\WO2ZXSge4l1cCCyR1yzMYhQ[yxicFPEUmEucF[GUjDhcoQheGiUTD3UT{Bie3Onc4Pl[EBieyCjc4Pld5Nm\CCjczD0doFve2O{aYD0bY9v[WxiYXP0bZZifGmxbjDt[YF{fXKnZDCyOEBpenNicH;zeEBqdm[nY4Tpc44h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyIE2gNE4xODByMTFOwG0v MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTh6OUOzOEc,OjF6OEmzN|Q9N2F-
SK-MEL-188 M2\RSGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NXO0dGpIPDhiaILz NH20OpRIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBUUy2PRVytNVg5KGOnbHzzJI1m[XO3cnXkJIFnfGW{IES4JIhzeyCkeTDNWHMwWE2VIHHzd4F6NCCLQ{WwJF0hOC5yMECwNUDPxE1w NG\o[JQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{C3NFc4QSd-MkewO|A4Pzl:L3G+
osteosarcoma cells NYS0[GhVTnWwY4Tpc44h[XO|YYm= NIfZdI5G\m[nY4Sgc44hXkSUIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCrbjDoeY1idiCxc4Tlc5NiemOxbXGgZ4VtdHNuIFXDOVAhRSByLkCwNFAyODZizszNMi=> M4[xOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6MEW0NlMxLz5zOEC1OFI{ODxxYU6=
HOS/SF NF3p[m1HfW6ldHnvckBie3OjeR?= Mni5NlQhcHK| M1Hq[3Rz[W6|YXP0bZZifGmxbjDv[kBXTFJvbXXkbYF1\WRib4P0[Y9k[WylaX6gdJJwdW:2ZYKgbY4hcHWvYX6gTG9UN1OIIHPlcIx{KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkCwNFAzPiEQvF2u M2PpVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwO|I5Lz5{NEmwNFczQDxxYU6=
LM05e NFHjOllCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NV7SSG5nPzJiaILz Ml\pRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDtc5V{\SCOTUC1[UBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiClZXzsJI52dWKncjDh[pRmeiB5MjDodpMh[nliV2PUJIF{e2G7LDDJR|UxKD1iMD6wNFAxOyEQvF2u MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEOzPUc,OjR7MECzN|k9N2F-
HEK293 MnXkSpVv[3Srb36gZZN{[Xl? MnjmWJJidnO{ZYDy[ZN{cW:wIH;mJHZROTZvdHHn[4VlKF[GUjCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiaHHyZo9zcW6pIIDDUXguT0GOND3OR49TKGGwZDDNTFExOCiXQWOpJHghPHStLVzVR{Bz\XCxcoTldkBxdGG|bXnkJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIF7Dc3IhemWlcoXpeI1mdnRiYomgZoV1[S2pYXzhZ5Rwe2mmYYPlJJJmeG:{dHXyJIdmdmViYnHz[YQhdWGvbXHsbYFvKHS5bz3ofYJzcWRiYYPzZZktKEmFNUCgQUAxNjByMEC1JO69VS5? MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl6OUixO{c,Ojl7OEm4NVc9N2F-
HEK293 MYjGeY5kfGmxbjDhd5NigQ>? MkfjWJJidnOjY4TpeoF1cW:wIH;mJHZROTZvdHHn[4VlKF[GUjCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiaHHyZo9zcW6pIIDDUXguT0GOND3SXHJidHCqYTDhcoQhVUhzMECoWWFUMSC[IET0b{1NXUNicnXwc5J1\XJicHzhd41q\CCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBqdnSncnHjeIlwdiC5aYToJHJZWmGucHjhJIJ6KGKndHGt[4Ft[WO2b4Pp[IF{\SC{ZYDvdpRmeiCpZX7lJIJie2WmIH3hcY1idGmjbjD0e48uNCCHQ{WwJF0hOC5yMECwO{DPxE1w NWHrT|J4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5PFk5OTdpPkK5PVg6QDF5PD;hQi=>
HEK293T MlS3SpVv[3Srb36gZZN{[Xl? M4XZW2Fod26rc4SgZYN1cX[rdImgZZQhT0GONDDEUmEu[mmwZHnu[{Bld22jaX6g[pV{\WRiVlTSJEh2dmuwb4fuJI9zcWerbjmgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDVRXMu[myjIFjFT{AzQTOWIHPlcIx{KGG|c3Xzd4VlKGG|IHLleIEudGGldHHtZZNmKHS{YX7zZ5JqeHSrb37hcEBi[3SrdnH0bY9vKGK7IF\SSXQu[mG|ZXSgS4Vv\UKOQYrldkBie3OjeTygTWM2OCB;IECuNFAxODl3MzFOwG0v MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF2NE[5O{c,OzBzNES2PVc9N2F-
HEK293 MkG4SpVv[3Srb36gZZN{[Xl? NHOxbFhC\2:waYP0JIFkfGm4aYT5JIF1KF[GUjCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiY3;0doFve2[nY4Tl[EB4cXSqIF7Dc3Ih[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gUmNwWiC{ZXPyeYl1dWWwdDDifUB1f29vaInidollKGG|c3H5MEBKSzVyIE2gNE4xODBzIN88UU4> NHKzVlU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nk[xN|QzOCd-Mk[2NVM1OjB:L3G+
HEK293 NXqyT5ozTnWwY4Tpc44h[XO|YYm= Mlz6NVYhfG9iMkSgbJJ{ MVTB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCrbjDoeY1idiCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhfHKjboPjdolxfGmxbnHsJIFkfGm4aYT5JIFnfGW{IEG2JJRwKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTBiPTCwMlAxODF{IN88UU4> MonPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ4MUO0NlAoRjJ4NkGzOFIxRC:jPh?=
ROS 17/2.8 M1e4e2Z2dmO2aX;uJIF{e2G7 MoPtNVYhcHK| MVnBZ5Rqfmm2eTDheEBXTFJiaX6gdoF1KFKRUzCxO{8zNjhiY3XscJMh[XO|ZYPz[YQh[XNidILhcpNkemmydHnvcoFtKGGldHn2ZZRqd25ib3[gNlQucHmmcn;4fYxie2ViZ3Xu[UBxem:vb4TldkBi\nSncjCxOkBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwJF0hOC5yMECyJO69VS5? MmmyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzNke4PVMoRjF7MU[3PFk{RC:jPh?=
osteosarcoma cells NH\sUIVHfW6ldHnvckBie3OjeR?= MXjBZ5Rqfmm2eTDheEBXTFJiaX6gdoF1KG:|dHXvd4Fz[2:vYTDj[YxteyCjc4Pld5Nm\CCjczCyOE1pgWS{b4j5cIF{\SC2cnHud4NzcXC2aX;uJIJ6KHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkCwNFIh|ryPLh?= NV;lZYlvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5OlA6OjRpPkG3PVYxQTJ2PD;hQi=>
ROS 17/2.8 M37keGZ2dmO2aX;uJIF{e2G7 NUfaNWlZOTZiaILz MWrBZ5Rqfmm2eTDheEBz[XRicnXjc41jcW6jboSg[pVtdCCuZX7neIghXkSUIHX4dJJme3OnZDDpckBz[XRiUl;TJFE4NzJwODDj[YxteyC2cnHud4Zm[3SnZDD3bZRpKDJ2LXj5[JJwgHmuYYPlJIdmdmVicILvcY91\XJiYYPz[ZN{\WRiYYOgeJJidnOlcnnweIlwdmGuIHHjeIl3[XSrb36gZYZ1\XJiMU[gbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3MDC9JFAvODByMjFOwG0v NF3WZZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEeyNlE{OCd-MUi3NlIyOzB:L3G+
ROS 17/2.8 NEHRR3RHfW6ldHnvckBie3OjeR?= NFPQW40yPiCqcoO= NX;qfoFvSWO2aY\peJkh[XRicnH0JJJm[2:vYnnuZY51KG[3bHygcIVv\3SqIG\EVkBmgHC{ZYPz[YQhcW5icnH0JHJQWyBzNz:yMlgh[2WubIOgeJJidnOoZXP0[YQhf2m2aDCyOE1pgWS{b4j5cIF{\SCpZX7lJJBzd22xdHXyJIF{e2W|c3XkJIF{KHS{YX7zZ5JqeHSrb37hcEBi[3SrdnH0bY9vKGGodHXyJFE3KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFvpJF0hOC5yMECyJO69VS5? MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTFyNU[3O{c,OjFzMEW2O|c9N2F-
ROS 17/2.8 NX\QPGtbTnWwY4Tpc44h[XO|YYm= NFjuTYgyPiCqcoO= MXjB[49vcXO2IHHjeIl3cXS7IHH0JJJifCCYRGKgbY4hWk:VIEG3M|IvQCClZXzsd{B1emGwc3\lZ5Rm\CC5aYToJGN6eDJ2YUGgdoVxd3K2ZYKgdIxie22rZDDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCFeYCyOIEyKHS{YX7zZ5JqeHSrb36gZYZ1\XJiMU[gbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3MDC9JFAvODByMjFOwG0v M3X1UFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEG4PVE5Lz5{MkCxPFkyQDxxYU6=
osteosarcoma cells NIO2cXZHfW6ldHnvckBie3OjeR?= MXHJcoR2[3Srb36gc4YhXkSULX3l[IlifGWmIEK0MYh6\HKxeInsZZNmKHS{YX7zZ5JqeHSrb36gbY4hemG2IH;zeIVwe2G{Y3;tZUBk\WyuczDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXEOVAhRSByLkCwNFIh|ryPLh?= M2nMUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzOUCyNlM2Lz5{MUmwNlI{PTxxYU6=
osteosarcoma cells M4HmVGZ2dmO2aX;uJIF{e2G7 NUDMboI6XHKjboPhZ5RqfmG2aX;uJI9nKF[GUjDpckBz[XRib4P0[Y9{[XKlb33hJINmdGy|IHHzd4V{e2WmIHHzJFI1NWi7ZILvfJlt[XOnIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWGNUCgQUAxNjByMEKg{txONg>? NXXBS4NERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[2N|A1PDRpPkK2OlMxPDR2PD;hQi=>
osteosarcoma cells MYrGeY5kfGmxbjDhd5NigQ>? NH3FW3AyPiCqcoO= MWfJcohq[mm2aX;uJI9nKF[GUj3pcoR2[2WmIEK0MYh6\HKxeInsZZNmKHS{YX7zZ5JqeHSrb36gbY4hemG2IH;zeIVwe2G{Y3;tZUBk\WyuczDh[pRmeiBzNjDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGTDVyIE2gNE4xODB{IN88UU4> M2XjelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NEmwNFExLz5{MkS5NFAyODxxYU6=
osteosarcoma cells M1zJTmZ2dmO2aX;uJIF{e2G7 M1jjTWFkfGm4aYT5JIF1KF[GUjDpckBz[XRib4P0[Y9{[XKlb33hJINmdGy|IHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iB{ND3ofYRzd3i7bHHz[UBz\XCxcoTldkBo\W6nIITyZY5{[3KrcITpc44h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyIE2gNE4xODB|IN88UU4> NFTvXXk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUixPVcxOid-MUm4NVk4ODJ:L3G+
HuH7 M1rpcmZ2dmO2aX;uJIF{e2G7 NX22c4J[OjRiaILz M{iy[mFod26rc4SgZYN1cX[rdImgZZQhXkSUIHX4dJJme3OnZDDpckBpfW2jbjDIeWg4KGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDwSHI{NWy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OCB;IECuNFAxOyEQvF2u MnztQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdzNEWwO|EoRjJ5MUS1NFcyRC:jPh?=
ROS 17/2.8 MX3GeY5kfGmxbjDhd5NigQ>? MmG0Wol1[W2rbjDEN{Bz\WOncITvdk1u\WSrYYTl[EB1emGwc3PybZB1cW:wYXygdI91\W6leTDpckBz[XRib4P0[Y9{[XKlb33hJHJQWyBzNz:yMlgh[2WubIOsJGVFPTBiPTCwMlAxODN3IN88UU4> NXPOWWFYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC0O|kzPzZpPkGwOFc6Ojd4PD;hQi=>
ROS 17/2.8 NYm4[VBuTnWwY4Tpc44h[XO|YYm= NVzL[HhHUW5idnn0do8hfmm2YX3pckBFKHKnY3XweI9zKCiYRGKpMY1m\GmjdHXkJJRz[W6|Y4LpdJRqd26jbDDwc5RmdmO7IHnuJJJifCCxc4Tlc5NiemOxbXGgVm9UKDF5L{KuPEBk\WyuczygSWQ2OCB;IECuNFAxOzZizszNMi=> MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTByMECxOEc,OTFyMECwNVQ9N2F-
ROS 17/2.8 MUTGeY5kfGmxbjDhd5NigQ>? NX\2fHRRUW5idnn0do8hfmm2YX3pckBFKHKnY3XweI9zNW2nZHnheIVlKGGwdHnwdo9tcW[ncnH0bZZmKGGldHn2bZR6KGmwIILheEBwe3Snb4PhdoNwdWFiUl;TJFE4NzJwODDj[YxteyxiRVS1NEA:KDBwMECwOEDPxE1w NYPEfJZCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG5N|E3OjdpPkGxPVMyPjJ5PD;hQi=>
COS7 MUTGeY5kfGmxbjDhd5NigQ>? MXfJcoR2[3Srb36gc4YhfHKjboPhZ5RqfmG2aX;uJI9nKGi3bXHuJHZFWiC{ZYPwc45{cX[nIHflcoUhcW5iQ1;TO{Bk\WyuczDifUBz[XRib4P0[Y9xd262aX6gcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwJF0hOC5yMEC1JO69VS5? M2LGd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5Mkm4NFQ2Lz5zN{K5PFA1PTxxYU6=
COS7 Ml7wSpVv[3Srb36gZZN{[Xl? MmruNlQhcHK| MkntRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDWSHIhcW5iQ1;TO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZidILhcpNkemmydHnvcoFtKHS{YX7zZYN1cX[jdHnvckBi\nSncjCyOEBpenNiYomgcY92e2Vib4P0[Y9xd262aX6gcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwJF0hOC5yMEC1JO69VS5? M1juS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5OUC0N|cxLz5zN{mwOFM4ODxxYU6=
SVEC NIHOSFhCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NFnST3M4OiCqcoO= M1fEOmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViU2\FR{Bk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiClZXzsJI52dWKncjDh[pRmeiB5MjDodpMh[nliV2PUJIF{e2G7LDDJR|UxKD1iMD6wNFA2OiEQvF2u M1fB[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwN|M6Lz5{NEmwNFM{QTxxYU6=
osteosarcoma cells M4nuNWZ2dmO2aX;uJIF{e2G7 NVqzcWljTW[oZXP0JI9vKF[GUjD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliaX6gbJVu[W5ib4P0[Y9{[XKlb33hJINmdGy|IHnuJJBz\XOnbnPlJI9nKDVnIH\leIFtKGOjbH[gd4VzfW1uIFXDOVAhRSByLkCwNFU2PSEQvF2u NFvIfoY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEC1OFI{OCd-MUiwOVQzOzB:L3G+
HEK293 MYPGeY5kfGmxbjDhd5NigQ>? MYTB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[2:2cnHud4Zm[3SnZDD3bZRpKFK[UnHsdIhiKGG|c3Xzd4VlKGG|IGLYVoFteGijIILlZ5J2cXSvZX70JIJ6KHS5bz3ofYJzcWRiYYPzZZktKEWFNUCgQUAxNjByME[g{txONg>? MkT1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ4MUO0NlAoRjJ4NkGzOFIxRC:jPh?=
CV1 M{LudWZ2dmO2aX;uJIF{e2G7 Mnv1RYN1cX[rdImgc44hcHWvYX6gWmRTNW2nZHnheIVlKHS{YX7zZ5JqeHSrb36gc4Yhd3O2ZX;jZYxkcW5iVlTSSUBnfXOnZDD0c{B1cHmvaXTpcoUhc2mwYYPlJJBzd22xdHXyM4dzd3e2aDDoc5Jud26nIILldI9zfGW{IHflcoUhcW5iQ2[xJINmdGy|LDDFSFUxKD1iMD6wNFA4KM7:TT6= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzF2OUi4NEc,OTdzNEm4PFA9N2F-
NHEK NELMS5pCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NEnWflEzPCCqcoO= M1fP[GFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgUmhGUyClZXzsd{BqdmO3YnH0[YQh\m:{IEK0JIhzeyCkeTDbN2hefGi7bXnkbY5mKGmwY3;ydI9z[XSrb36gZZN{[XluIFXDOVAhRSByLkCwNFczQCEQvF2u M1vIUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NEC0N|I3Lz5{MkSwOFMzPjxxYU6=
COS1 NGq2epBHfW6ldHnvckBie3OjeR?= M4jCZmRqe3CuYXPlcYVvfCCxZjCxMYFteGijLDCyOU0pV0hrW{PIYWQ{KG[{b32gbJVu[W5iVlTSJIV5eHKnc4Pl[EBqdiCFT2OxJINmdGy|LDDJR|UxKD1iMD6wNFA5KM7:TT6= NUfiem5nRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5NlQ3OTZpPkG3PVI1PjF4PD;hQi=>
HEK293 NXTEeW84TnWwY4Tpc44h[XO|YYm= M{PtblI1KGi{cx?= NF\CfphC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHZFWiCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJJRz[W6|Y4LpdJRqd26jbDD0doFve2GldHn2ZZRqd25iYX\0[ZIhOjRiaILzJIJ6KG2xdYPlJI9{fGWxcH;ueIlvKGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OCB;IECuNFAyKM7:TT6= MoPsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd7MESzO|AoRjF5OUC0N|cxRC:jPh?=
HL60 NXPN[IdsTnWwY4Tpc44h[XO|YYm= M3;qNGlv\HWldHnvckBw\iCqdX3hckBJVDZyIHTp[oZmemWwdHnheIlwdiCjc4Pld5Nm\CCjczDj[YxteyC{ZXT1Z4lv\yCwaYTyc{BjdHWnIITleJJigm:uaYXtMEBGTDVyIE2gNE4xODFizszNMi=> MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTlyMkKzOUc,OjF7MEKyN|U9N2F-
HeLa MXXGeY5kfGmxbjDhd5NigQ>? M{GxXFE3KGi{cx?= NHuzVHZVemGwc3HjeIl3[XSrb36gc4YhT0GOND3meZNm\CCYRGKgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDoeY1idiCKZVzhJINmdGy|IHHmeIVzKDF4IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTBiPTCwMlAxOSEQvF2u MluwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7NUe4N|QoRjJ{OUW3PFM1RC:jPh?=
T47D M4jycmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MWW3NkBpenN? MYHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFR2N1SgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4h[2WubDDueY1j\XJiYX\0[ZIhPzJiaILzJIJ6KFeVVDDhd5NigSxiSVO1NEA:KDBwMECxN{DPxE1w NWjsZ5JwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA{OzlpPkK0PVAxOzN7PD;hQi=>
ROS 17/2.8 MV\GeY5kfGmxbjDhd5NigQ>? M4jYPWFkfGm4aYT5JIF1KGi3bXHuJJJm[2:vYnnuZY51KF[GUjDpckBTV1NiMUevNk45KGOnbHzzJJRz[W6|ZnXjeIVlKHerdHig[5Jwf3SqIHjvdo1wdmViZoXzbY9vKGenbnWgWmRTTSCjc4Pld5Nm\CCjczDndo94fGhiaH;ycY9v\SCuZY\lcEBjgSC2cnHud4NzcXC2aX;uZYwh[XO|YYmsJGVFPTBiPTCwMlAxOTVizszNMi=> NHL4UVg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{myOFYyPid-MUe5NlQ3OTZ:L3G+
HEK293 NVnBXo1XTnWwY4Tpc44h[XO|YYm= M3jKZ|I1KGi{cx?= NYLXbGlrXHKjboPhZ5RqfmG2aX;uJI9nKHKnY3;tZolv[W62IHj1cYFvKF[GUj;SXHJidHCqYTDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCGdXHsMYx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NEA:KDBwMECxOVgh|ryPLh?= NXvL[WN4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CxPVMzOTZpPkOwNVk{OjF4PD;hQi=>
MCF7 MY\GeY5kfGmxbjDhd5NigQ>? M33rS|I1KGi{cx?= MXXB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCrbjDoeY1idiCPQ1[3JINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKHS{YX7zZ5JqeHSrb36gc4YhS1mSMkTBNUBo\W6nIHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTBiPTCwMlAxOTZizszNMi=> M33CNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7N{OzOlQ2Lz5{OUezN|Y1PTxxYU6=
MCF10DCIS.com MVnBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M1nZXVMh\GG7cx?= MmDmRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDFVkBxd3OrdHn2[UBpfW2jbjDNR2YyOESFSWOuZ49uKGOnbHzzJIFnfGW{IEOg[IF6eyCkeTDbN2hefGi7bXnkbY5mKHWydHHr[UBie3OjeTygTWM2OCB;IECuNFAyPzVizszNMi=> M1rlS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MUiwPFM4Lz5{MkG4NFg{PzxxYU6=
HL60 Mn;qSpVv[3Srb36gZZN{[Xl? MWXJcoR2[3Srb36gc4Yh\GmoZnXy[Y51cW:wIH;mJIh2dWGwIFjMOlAh[2WubIOgbY51dyCvb37vZ5l1\XNiYomgUmJVKHKnZIXjeIlwdiCjc4PhfUwhTUN3MDC9JFAvODB{IN88UU4> M{faeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5OU[wPVI1Lz5zN{m2NFkzPDxxYU6=
HL-60 MVTGeY5kfGmxbjDhd5NigQ>? MmHKOEBl[Xm| MVPJcoR2[3Srb36gc4Yh\GmoZnXy[Y51cWG2aX;uJI9nKGi3bXHuJGhNNTZyIHPlcIx{KHC{b335[Yxw[3m2ZYOgeI8hdW:wb3P5eIV{KGGodHXyJFQh\GG7czDifUBPSlRicnXkeYN1cW:wIHHzd4F6NCCHQ{WwJF0hOC5yMEKg{txONg>? NHfEWXY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEeyNlE{OCd-MUi3NlIyOzB:L3G+
bone marrow cells MVjGeY5kfGmxbjDhd5NigQ>? M3r2TFMh\GG7cx?= NGTsTnVG\m[nY4Sgc44hd3O2ZX;jcIF{fCCob4LtZZRqd25iaX6g[IR[KG2xdYPlJIJwdmVibXHydo94KGOnbHzzJINwKGO3bIT1doVlKHerdHigdJJqdWG{eTDvd5Rmd2OuYYP0d{Bi\nSncjCzJIRigXNuIFXDOVAhRSByLkCwNkDPxE1w MoXEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3M{mwN|QoRjF6NUO5NFM1RC:jPh?=
HL60 M1rzWGZ2dmO2aX;uJIF{e2G7 M3LMVlQh\GG7cx?= M2q2cGlv\HWldHnvckBw\iCmaX\m[ZJmdnSrYYTpc44hd2ZiaIXtZY4hUEx4MDDj[YxteyCycn;tfYVtd2O7dHXzJJRwKG2xbn;jfZRmeyCjZoTldkA1KGSjeYOgZpkhVkKWIILl[JVkfGmxbjDhd5NigSxiS3mgQUAxNjByMjFOwG0v NUH1UogxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxNFU3PzdpPkKxNVA2Pjd5PD;hQi=>
HeLa MUHGeY5kfGmxbjDhd5NigQ>? NH;GdncyQCCqcoO= NV7YNppoXHKjboPhZ5RqfmG2aX;uJI9nKG[3bHygcIVv\3SqIHj1cYFvKF[GUjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVN[SClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDDXXAzPCC2cnHud4NzcXC2aX;uJIFnfGW{IEG4JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUCgQUAxNjByMkWg{txONg>? M3\6VVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OUW3PFM1Lz5{Mkm1O|g{PDxxYU6=
PBMC NH\WNGJHfW6ldHnvckBie3OjeR?= MkDLTY4hfmm2cn:gbY5pcWKrdHnvckBw\iCyaIn0c4hmdWGpZ3z1eIlvcW6rbj3pcoR2[2WmIIP0bY12dGG2aX;uJI9nKGi3bXHuJJBmemmyaHXyZYwh[myxb3SgcY9vd263Y3zlZZIh[2WubIOgdJJwdGmoZYLheIlwdixiRVS1NEA:KDBwMECyO{DPxE1w MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTByMECxOEc,OTFyMECwNVQ9N2F-
HL60 MYPGeY5kfGmxbjDhd5NigQ>? NWfhW2FKUW6mdXP0bY9vKG:oIHPlcIwh\GmoZnXy[Y51cWG2aX;uJI9nKGi3bXHuJGhNPjBiY3XscJMhfG9ibX;uc4N6fGW|IHL5JG5DXCC{ZXT1Z5Rqd25iYYPzZZktKEWFNUCgQUAxNjByMzFOwG0v NFruXIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUG2O|g6Oyd-MUmxOlc5QTN:L3G+
HEK293 MoDtSpVv[3Srb36gZZN{[Xl? MkLoRYdwdmm|dDDhZ5Rqfmm2eTDheEBEVVhvR1HMOEB1[WepZXSgbJVu[W5iVlTSJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5idILhcpNkemmydHnvcoFtKGGldHn2bZR6KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3MDC9JFAvODB|IN88UU4> MlL3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2NkK3NVUoRjJ|NE[yO|E2RC:jPh?=
MCF7 NGTSfG1HfW6ldHnvckBie3OjeR?= M2\TRlI1KGi{cx?= MYLB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCrbjDoeY1idiCPQ1[3JINmdGy|IHHzd4V{e2WmIHHzJJRz[W6|Y4LpdJRqd25ib3[gR3lROjSDMTDn[Y5mKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkCwN|I5KM7:TT6= NFzRZnE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mkm4PVM4QSd-MkK5PFk{Pzl:L3G+
Caco-2 M1LMfGZ2dmO2aX;uJIF{e2G7 NGLxRm5G\m[nY4Sgc44hXkSUIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCrbjDoeY1idiCFYXPvMVIh[2WubIOgbY4heHKnc3XuZ4Uhd2ZiNTWg[oV1[WxiY3Hs[kB{\XK3bTygSWM2OCB;IECuNFA{PTJizszNMi=> Mk\zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOThyNUSyN|AoRjF6MEW0NlMxRC:jPh?=
MCF10AT1 NVPYXYx{SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NFTyOmE{KGSjeYO= M4S0OmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgSXIheG:|aYTpeoUhcHWvYX6gUWNHOTCDVEGgZ4VtdHNiYX\0[ZIhOyCmYYnzJIJ6KFt|SG30bJlucWSrbnWgeZB1[WunIHHzd4F6NCCLQ{WwJF0hOC5yMEO5JO69VS5? NGTzS3k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkG4NFg{Pyd-MkKxPFA5Ozd:L3G+
Jurkat M3fGZWZ2dmO2aX;uJIF{e2G7 MkPXNlQhcHK| NH[1clBC[3SrdnH0bY9vKG:oIG\EVkBqdiCqdX3hckBLfXKtYYSgZ4VtdHNiZYjwdoV{e2mwZzDs[Y51cX[rcnHsJHZFWkVvbIXjbYZmemG|ZTD2[YN1d3JiYYPz[ZN{\WRiYYOgWmRTTS2vZXTpZZRm\CC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkhdWWjc4Xy[YQh[W[2ZYKgNlQhcHK|IHL5JIx2[2moZYLhd4UhfHKjboPjdolxfGmxbnHsJJJmeG:{dHXyJIF{e2G7LDDFR|UxKD1iMD6wNFM6OzZizszNMi=> NFzESoQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{C3NFc4QSd-MkewO|A4Pzl:L3G+
MCF7 NFfze|NHfW6ldHnvckBie3OjeR?= NWThdWkzSWexbnnzeEBi[3Srdnn0fUBifCC8ZXLyZYZqe2hiZ3HsOE1XTFJiTFLEJIV5eHKnc4Pl[EBqdiCqdX3hckBOS0Z5IHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCkYYPl[EB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVAhRSByLkCwOVUh|ryPLh?= MlTZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzOEC4N|coRjJ{MUiwPFM4RC:jPh?=
MCF10CA1a MXzBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MmewN{Bl[Xm| MXjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IFXSJJBwe2m2aY\lJIh2dWGwIF3DSlExS0FzYTDj[YxteyCjZoTldkA{KGSjeYOgZpkhYzOKXYTofY1q\GmwZTD1dJRic2ViYYPzZZktKEmFNUCgQUAxNjByNkKg{txONg>? NUXzbnIyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxPFA5OzdpPkKyNVgxQDN5PD;hQi=>
HL60 NYL5WZJTTnWwY4Tpc44h[XO|YYm= MnTYPVYhcHK| M3jjbmFod26rc4SgZYN1cX[rdImgZZQhXkSUIHnuJIh2dWGwIFjMOlAh[2WubIOgZZN{\XO|ZXSgZZMhcW6mdXP0bY9vKG:oIHPlcIwh\GmoZnXy[Y51cWG2aX;uJIFnfGW{IEm2JIhzeyCkeTDORnQh[XO|YYmsJGVEPTBiPTCwMlAxQSEQvF2u M4LTcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUG4N|E6Lz5{OUWxPFMyQTxxYU6=
HL-60 MoHzSpVv[3Srb36gZZN{[Xl? MVe5OkBpenN? M4H5cWFod26rc4SgZYN1cX[rdImgZZQhfmm2YX3pckBFOyC{ZXPldJRweiCrbjDoeY1idiCKTD22NEBk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiY3XscEBlcW[oZYLlcpRq[XSrb36gZYZ1\XJiOU[gbJJ{KGK7IF7CWEBlgWVvYnHz[YQhdWmlcn;zZ49xcWNiYX7hcJl{cXNuIFXDOVAhRSByLkCwPUDPxE1w M{TLflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NU[yOVQzLz5{NkW2NlU1OjxxYU6=
THP1 Mmq1SpVv[3Srb36gZZN{[Xl? M{nPdWFkfGm4YYTpc44hd2ZiVlTSJIlvKGi3bXHuJHRJWDFiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gNlUucHmmcn;4fZZqfGGvaX6gSE0zPC2qeXTyc5h6dGG|ZTDtVm5CKGW6cILld5Nqd25iYomgVnQuWEOULDDFR|UxKD1iMD6wNUDPxE1w M3e1S|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7M{C5NVU2Lz5zOUOwPVE2PTxxYU6=
THP1 MXnGeY5kfGmxbjDhd5NigQ>? M1LPWGFkfGm4YYTpc44hd2ZiVlTSJIlvKGi3bXHuJHRJWDFiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZ4F1cGWuaXPp[IlvKGGwdHntbYNzd2KrYXygdIVxfGmmZTDtVm5CKGW6cILld5Nqd25iYomgVnQuWEOULDDFR|UxKD1iMD6wNUDPxE1w NYXh[mNJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmzNFkyPTVpPkG5N|A6OTV3PD;hQi=>
ROS 17/2.8 MoC4SpVv[3Srb36gZZN{[Xl? NHjJV2NG\m[nY4TpeoUh\G:|ZTDmc5IhfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44hcW5iUl;TJFE4NzJwODDvd5Rmd3OjcnPvcYEh[2WubIOsJGVFPTBiPTCwMlAyKM7:TT6= NFe3VmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMEi5N|MxQSd-MUC4PVM{ODl:L3G+
HL60 M4XG[mZ2dmO2aX;uJIF{e2G7 M4rXTFE1PCCqcoO= M37oZ2lv\HWldHnvckBw\iClZXzsJIRq\m[ncnXueIlifGmxbjDv[kBpfW2jbjDIUFYxKGOnbHzzJIlv[3WkYYTl[EBnd3JiMUS0JIhzeyCkeTDXd5QuOSCmeXWgZoF{\WRiYYPzZZktKEmFNUCgQUAxNjB3IN88UU4> M1XoUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUiwPVI3Lz5{NUG4NFkzPjxxYU6=
MCF7 M1zqV2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 MnX6O|IhcHK| MkHiRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3JINmdGy|IHHmeIVzKDd{IHjyd{BjgSCdM1jdeIh6dWmmaX7lJIlv[2:{cH;yZZRqd25iYYPzZZktKEWFNUCgQUAxNjB3MjFOwG0v M3TkNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7N{O5OlczLz5zOUezPVY4OjxxYU6=
bone marrow cells NHzXXJpHfW6ldHnvckBie3OjeR?= NXP6cnlOOyCmYYnz NVv2UllOTW[oZXP0JI9vKG:|dHXvZ4xie3RiZn;ycYF1cW:wIHnuJIRlYSCvb4Xz[UBjd26nIH3hdpJwfyClZXzsd{BkdyCldXz0eZJm\CC5aYToJJBzcW2jcomgc5N1\W:lbHHzeJMh[W[2ZYKgN{Bl[Xm|IILlcIF1cX[nIITvJFEu[WyyaHGsJFI2NSiRSDmySFMtKEWFNUCgQUAxNjFizszNMi=> M2HpTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUO5NFM1Lz5zOEWzPVA{PDxxYU6=
HL-60 MWrGeY5kfGmxbjDhd5NigQ>? M{PIOmlvcGmkaYTpc44hd2ZiY3;sc456KG[xcn3heIlwdiCjc4PhfZMhd25iSFytOlAh[2WubIOsJGVFPTBiPTCwMlE{KM7:TT6= M1;uV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFyOEmzN|A6Lz5zMEi5N|MxQTxxYU6=
Caco2 NXn2TpVVTnWwY4Tpc44h[XO|YYm= MXWyOEBpenN? M1\WbGFkfGm4YYTpc44hd2ZiVlTSJIlvKGi3bXHuJGNi[29{IHPlcIx{KGW6cILld5NqdmdibHXueIl3cXKjbDDWSHJGNWy3Y3nm[ZJie2VidnXjeI9zKGG|c3Xzd4VlKGG|IG\EVmUudWWmaXH0[YQhfHKjboPjdolxfGmxbnHsJIFkfGm4aYT5JI1m[XO3cnXkJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJRz[W6|Y4LpdJRqd26jbDDy[ZBwenSncjDhd5NigSxiRVO1NEA:KDBwMkKzOEDPxE1w M{n4TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MEewO|c6Lz5{N{C3NFc4QTxxYU6=
HaCaT NGm0[JpHfW6ldHnvckBie3OjeR?= M1P4VVI1KGi{cx?= MWnBZ5RqfmG2aX;uJI9nKF[GUjDpckBpfW2jbjDIZWNiXCClZXzsd{BmgHC{ZYPzbY5oKGynboTpeolz[WxiVlTSSU1tfWOrZnXyZZNmKH[nY4TvdkBie3Onc4Pl[EBieyCYRGLFMY1m\GmjdHXkJJRz[W6|Y4LpdJRqd26jbDDhZ5Rqfmm2eTDt[YF{fXKnZDDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTD0doFve2O{aYD0bY9v[WxicnXwc5J1\XJiYYPzZZktKEWFNUCgQUAxNjJ2OUeg{txONg>? MnvlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdyN{C3O|koRjJ5MEewO|c6RC:jPh?=
HaCaT M1T6[WZ2dmO2aX;uJIF{e2G7 MW[yOEBpenN? NXfEWHl3XHKjboPhZ5RqfmG2aX;uJI9nKF[GUjDpckBpfW2jbjDIZWNiXCClZXzsd{Bi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwJF0hOC5|MkG1JO69VS5? NUnqeVBjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[zOlcxOTlpPkK2N|Y4ODF7PD;hQi=>
MCF-7 MX3GeY5kfGmxbjDhd5NigQ>? NHK4eFJKdmirYnn0bY9vKG:oIHPvcI9vgSCob4LtZZRqd25iYYPzZZl{KG:wIF3DSk04KGOnbHzzMEBGTDVyIE2gNE4{QCEQvF2u NVTWWpBQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC4PVM{ODlpPkGwPFk{OzB7PD;hQi=>
CV1 NYfWZnJrTnWwY4Tpc44h[XO|YYm= MWrF[oZm[3Rib36gWmRTNW2nZHnheIVlKHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBqdiCFVkGgZ4VtdHNidILhcpNn\WO2ZXSge4l1cCCqdX3hckBz\WOxbXLpcoFvfCCYRGKsJGVFPTBiPTCwMlQh|ryPLh?= NV[1UmpRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW2NVU2OzRpPkG1OlE2PTN2PD;hQi=>
Caco2 M{PxcGZ2dmO2aX;uJIF{e2G7 NEDmcXEzPCCqcoO= NEDw[YhVemGwc3HjeIl3[XSrb36gc4YhXkSUIHnuJIh2dWGwIFPhZ48zKGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUCgQUAxNjVzNUKg{txONg>? MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjN4N{CxPUc,OjZ|NkewNVk9N2F-
HN12 MmexRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MlXsO|IhcHK| M{fq[GFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSF6xNkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiClZXzsJI52dWKncjDh[pRmeiB5MjDodpMh[nliV2PUJIF{e2G7LDDJR|UxKD1iMD61OVMh|ryPLh?= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEOzPUc,OjR7MECzN|k9N2F-
L02 M{PEZmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NEL4UWs1QCCqcoO= M{HQcWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTECyJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLk[3JO69VS5? NYPkWlVoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm1NVg{OTlpPkK5OVE5OzF7PD;hQi=>
L02 M4ju[2N6fG:2b4jpZ4l1gSCjc4PhfS=> MlvhOFghcHK| M4OyOWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGwxOiClZXzsd{Bi\nSncjC0PEBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNE43PyEQvF2u M{fqPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NU[yOVQzLz5{NkW2NlU1OjxxYU6=
Caco2 NI\KbIFCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NXnGZZJkPDhiaILz M2\4TWFvfGmyb3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCFYXPvNkBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iND60JO69VS5? MmjkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ3NkK1OFIoRjJ4NU[yOVQzRC:jPh?=
Caco2 M1\QSGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NIDEeXM1QCCqcoO= MUDBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEOjY3:yJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB2LkS2JO69VS5? MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTVzOEOxPUc,Ojl3MUizNVk9N2F-
MCF7 NEC4PWRCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NIXOcmk1QCCqcoO= NGq0e4VCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEWuOVkh|ryPLh?= M4DjbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUG4N|E6Lz5{OUWxPFMyQTxxYU6=
MCF7 MYDBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M{jvUlQ5KGi{cx?= NUXodHJmSW62aYDvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEWuOkDPxE1w NYfnPWVyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[1OlI2PDJpPkK2OVYzPTR{PD;hQi=>
MCF7 NHXGPGdHfW6ldHnvckBie3OjeR?= MkLUNVYhcHK| NHW5ZnFDcW6maX7nJIFn\mmwaYT5JJRwKF[GUjDpckB{[3KjbXLs[YQhe2mUTlGteJJidnOoZXP0[YQhcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyClZXzsJIdzd3e2aDDpcohq[mm2aX;uJIJ6KG2nYYP1dolv\yC{ZXT1Z5Rqd25iaX6gRpJlXSCrbnPvdpBwemG2aX;uJIFnfGW{IEG2JIhzeyCkeTDFUGlUSSxiSVO1NEA:KDZwNEOg{txONg>? Mn3qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzOUOyNVYoRjNyMUmzNlE3RC:jPh?=
PC3 M{nTNmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 Mk\PNlQhcHK| M4\OXmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB7LkWzJO69VS5? MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF7M{KxOkc,OzBzOUOyNVY9N2F-
MCF7 MY\BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M33hUFI1KGi{cx?= NFTJWmZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEGxMlQ{KM7:TT6= Mmr2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzOUOyNVYoRjNyMUmzNlE3RC:jPh?=
MCF7 Mo[3RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M3n3Z|czKGi{cx?= NV;hbVhpSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gdJJwdGmoZYLheIlwdiCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOTJwNTFOwG0v NITPfms9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUGyO|E1QSd-MkWxNlcyPDl:L3G+
PC3 MXrBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NWTRUJZvPDhiaILz MYPBcpRqeG:uaX\ldoF1cX[nIHHjeIl3cXS7IHHnZYlve3RiaIXtZY4hWEN|IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyPy5{IN88UU4> NH\xfo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkW2NlU1Oid-Mk[1OlI2PDJ:L3G+
PC3 NVPrR5pLSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NGHmXHE1QCCqcoO= Mlv6RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSQ{OgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDF5LkK1JO69VS5? NH;GVmc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUWxPFMyQSd-Mkm1NVg{OTl:L3G+
BxPC3 M{jHb2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 MUeyOEBpenN? NVzVOHpRSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDCfHBEOyClZXzsd{Bi\nSncjCyOEBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNlEvODdizszNMi=> Mmq2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzOUOyNVYoRjNyMUmzNlE3RC:jPh?=
PBMC NX;pZ2FXTnWwY4Tpc44h[XO|YYm= Mn;lNVAhdk1? NVixcFkxfXBidH:gPEBpenN? Mk\hRYN1cX[jdHnvckBw\iCYRGKgbY4hVFCVLYP0bY12dGG2ZXSgbJVu[W5iUFLNR{Bk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiB{NT3ofYRzd3i7dnn0ZY1qdiCGLUK0MYh6\HKxeInsZZNmKG2UTlGg[ZhxemW|c3nvckBifCBzMDDuUUBi\nSncjD1dJRwKDhiaILzJIJ6KFKWLWDDVi=> MlzxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl|MEmxOVUoRjF7M{C5NVU2RC:jPh?=
THP1 MlfzSpVv[3Srb36gZZN{[Xl? MWrBZ5RqfmG2aX;uJI9nKF[GUjDpckBpfW2jbjDUTHAyKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHPheIhmdGmlaXTpckBidnSrbXnjdo9jcWGuIIDldJRq\GVibWLORUBmgHC{ZYPzbY9vKGG2IFXDOVAhfXC2bzC1JIhzeyCkeTDSWE1RS1J? MmPKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl|MEmxOVUoRjF7M{C5NVU2RC:jPh?=
NB4 NF3jcWpHfW6ldHnvckBie3OjeR?= MW[xJI5O MX60PEBpenN? M3\O[mlv\HWldHnvckBw\iClZXzsJIRq\m[ncnXueIlifGmxbjDpckBpfW2jbjDORlQh[2WubIOgZZN{\XO|ZXSgZZMhcW6mdXP0bY9vKG:oIHnu[JVkfGmxbjDv[kBk\WyuIIP1doZi[2VibXHyb4VzKEOGMUSg[ZhxemW|c3nvckBifCBzIH7NJIFnfGW{IES4JIhzew>? NHXae3g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[4OVg5QCd-MUm2PFU5QDh:L3G+
NB4 MV;GeY5kfGmxbjDhd5NigQ>? NV\QPZR4OSCwTR?= M2jxXlQ5KGi{cx?= MlzpTY5lfWO2aX;uJI9nKGOnbHyg[Iln\mW{ZX70bYF1cW:wIHnuJIh2dWGwIF7COEBk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiaX7keYN1cW:wIH;mJINmdGxic4Xy[oFk\SCvYYLr[ZIhS0RzMXKg[ZhxemW|c3nvckBifCBzIH7NJIFnfGW{IES4JIhzew>? NIOzSIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[4OVg5QCd-MUm2PFU5QDh:L3G+
HL60 NXf5[WlITnWwY4Tpc44h[XO|YYm= MUO0JIRigXN? MXzJcoR2[3Srb36gc4Yh[2WubDDkbYZn\XKnboTpZZRqd25iaX6gbJVu[W5iSFy2NEBk\WyuczDh[pRmeiB2IHThfZMh[nliTlLUJJJm\HWldHnvckBie3OjeR?= MnnFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzOUOwOVkoRjF7MUmzNFU6RC:jPh?=
HL60 NG\I[W5HfW6ldHnvckBie3OjeR?= NVPUOIR1OTBizszN MoD2TY5pcWKrdHnvckBw\iBzLEK1MUhQUCl{REOtbY5lfWOnZDDj[YxtKGSrZn\ldoVvfGmjdHnvckBqdiCqdX3hckBJVDZyIHPlcIx{KGG|c3Xzd4VlKGG|IH3vdpBpd2yxZ3njZYwh[2ijbnfld{BifCBzMDetOkBOKGK7IGfybYdpfC2JZXntd4Ehe3SjaX7pcoc> NIXOfYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUG5N|A2QSd-MUmxPVMxPTl:L3G+
SCC4 NHvITnhHfW6ldHnvckBie3OjeR?= NFTFeZUyKHWP MWi1JJRwKDFyIH3pcpM> MVjB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCrbjDoeY1idiCVQ1O0JINmdGy|IHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCFWWCyOEBo\W6nIHX4dJJme3Orb36gZZQhOSC3TTDh[pRmeiB3IITvJFExKG2rboOgZpkhWlRvUFPSJIFv[Wy7c3nz M{HVb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyNEWyNlI2Lz5{MES1NlIzPTxxYU6=
SCC25 M2HpUGZ2dmO2aX;uJIF{e2G7 MX2xNEBvVQ>? NVe2[ZhTSWexbnnzeEBi[3Srdnn0fUBifCCYRGKgbY4hcHWvYX6gV2NEOjViY3XscJMh[XO|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJGN[WDJ2IHX4dJJme3Orb36gZZQhOTBibl2= M1;tRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyOEizNFI3Lz5{MEi4N|AzPjxxYU6=
SCC25 M1HvUmZ2dmO2aX;uJIF{e2G7 NFTJRZgyODBibl2= MWfB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCrbjDoeY1idiCVQ1OyOUBk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiVGPMVEBmgHC{ZYPzbY9vKGG2IEGwNEBvVQ>? NIXSfVc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEi4N|AzPid-MkC4PFMxOjZ:L3G+
C3H10T1/2 NHHpWYxHfW6ldHnvckBie3OjeR?= NED3[ZUxNjVidH:gOUB2VQ>? MlToNlQhcHK| MXHJcohq[mm2aX;uJI9nKEinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGmwIH3veZNmKEN|SEGwWFEwOiClZXzsd{Bie3Onc4Pl[EBieyCmb4fuJJJm\3WuYYTpc44hd2ZiR3zpNUBifCByLkWgeI8hPSC3TTDh[pRmeiB{NDDodpMh[nliUmStVGNTKGGwYXz5d4l{ MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ{Nk[1O{c,OjJ{Mk[2OVc9N2F-
HL60 M4\uNGZ2dmO2aX;uJIF{e2G7 M{T2R|Eh|ryP NX;2OlV{UW6mdXP0bY9vKG:oII\peIFucW5iRDDy[YNmeHSxcj3t[YRq[XSnZDDkbYZn\XKnboTpZZRqd25ib3[gbJVu[W5iSFy2NEBk\WyuczDheEAyOCdvNTDNJIJ6KE6EVDDy[YR2[3Srb36gcYV1cG:m Ml;KQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{OEW5OFMoRjJ{Mki1PVQ{RC:jPh?=
HL60 M1zIRWZ2dmO2aX;uJIF{e2G7 NHvHR5YyKG6PIITvJFExKM7:TR?= M2rrb2lv\HWldHnvckBw\iC4aYThcYlvKERicnXj[ZB1d3JvbXXkbYF1\WRiZHnm[oVz\W62aXH0bY9vKG:oIHj1cYFvKEiONkCgZ4VtdHNiYYSgNVAoNTlidH:gNVAoNTViTTDifUBPSlRicnXkeYN1cW:wIH3leIhw\A>? MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ6NUm0N{c,OjJ{OEW5OFM9N2F-
A498 MlHkSpVv[3Srb36gZZN{[Xl? M3vN[|ExKG6P M1:0OlQhcHK| MmXjTY5lfWO2aX;uJI9nKEO\UEK0JI1TVkFiZYjwdoV{e2mxbjDpckBpfW2jbjDBOFk5KGOnbHzzJIF1KDFyJz24JG0h[W[2ZYKgOEBpenNiYomgVnQuWEOUIHHuZYx6e2m| M4C5b|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzM{myPVg{Lz5{MUO5Nlk5OzxxYU6=
A498 NWPJ[GVbTnWwY4Tpc44h[XO|YYm= MUSxNEBvVQ>? M2myO|E3KGi{cx?= NFHBRVFKdmS3Y4Tpc44hd2ZiQ2nQNlQhdVKQQTDlfJBz\XO|aX;uJIlvKGi3bXHuJGE1QThiY3XscJMh[XRiMUCnMVghVSCjZoTldkAyPiCqcoOgZpkhWlRvUFPSJIFv[Wy7c3nz MoTNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF|OUK5PFMoRjJzM{myPVg{RC:jPh?=
DU145 NG\a[nFHfW6ldHnvckBie3OjeR?= NIDhbWM4NjVidV2= MoLmNVghcHK| MYLB[49vcXO2IHHjeIl3cXS7IHH0JHZFWi2OQlSgbY4hcHWvYX6gSHUyPDViY3XscJMh[XO|ZYPz[YQh[XNiQ2nQNlRCOSCneIDy[ZN{cW:wIHH0JFcvPSC3TTDh[pRmeiBzODDodpMh[nlicWLUMXBEWiCvZYToc4Q> M331[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4N{e0PVI6Lz5{Nke3OFkzQTxxYU6=
HaCaT M{LBTmZ2dmO2aX;uJIF{e2G7 NF3hcm1KdmirYnn0bY9vKG:oIHPvcI9vgSCob4LtZZRqd25ib3[gbJVu[W5iSHHDZXQh[2WubIO= MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjRyNEOyOkc,OjJ2MESzNlY9N2F-
HCT116 NH;TUXJHfW6ldHnvckBie3OjeR?= NEHtWHAzOCC2bzC0NEB2VQ>? MmXxNlQhcHK| NVjVdWNTSWexbnnzeEBi[3Srdnn0fUBifCCUQWKgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO|ZXSgbY4hcHWvYX6gTGNVOTF4IHPlcIx{KGOxLXX4dJJme3OrbnegVmFTTSCjdDCyNEB1dyB2MDD1UUBi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6 MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzJ5NkS0PUc,OjN{N{[0OFk9N2F-
HCT116 M2DT[WZ2dmO2aX;uJIF{e2G7 MmK5NlAhfG9iNECgeW0> NVrXbWlZOjRiaILz NFjSSZZC\2:waYP0JIFkfGm4aYT5JIF1KFK[UjCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBpfW2jbjDIR3QyOTZiY3XscJMh[29vZYjwdoV{e2mwZzDSXHJGKGG2IEKwJJRwKDRyIIXNJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> NWjBdnU6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOyO|Y1PDlpPkKzNlc3PDR7PD;hQi=>
HEK293 MXzGeY5kfGmxbjDhd5NigQ>? MW[xNFAhdk1? MYSyOEBpenN? NUS5c3VsUW6mdXP0bY9vKG:oIHP5dFI1STFibWLORUBmgHC{ZYPzbY9vKGmwIFjFT|I6OyClZXzsd{BifCBzMECgcm0h[W[2ZYKgNlQhcHK|IHL5JJJm[WxvdHnt[UBRS1J? MlnnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5N{O1OlUoRjJ2N{ezOVY2RC:jPh?=
HEK293 MUTGeY5kfGmxbjDhd5NigQ>? NFXtV5kyOCCwTR?= NIfBN4pVemGwc3HjeIl3[XSrb36gc4YhcHWvYX6gWmRTKERzNEnBJI12fGGwdDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHPv[ZhxemW|c3nu[{BEYVB|QUSgZZQhOTBibl2gZpkh\HWjbDDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> NGHuUoI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEixPFg2Pyd-MkS4NVg5PTd:L3G+
HEK293 NEm3c2VHfW6ldHnvckBie3OjeR?= NGjRT3oyOCCwTR?= NEPPNYJVemGwc3HjeIl3[XSrb36gc4YhcHWvYX6gWmRTKEt{NEDBJI12fGGwdDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHPv[ZhxemW|c3nu[{BEYVB|QUSgZZQhOTBibl2gZpkh\HWjbDDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> M3nHTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEG4PFU4Lz5{NEixPFg2PzxxYU6=
MCF7 NGXINI5CdnSrdIXtc5Ih[XO|YYm= MkjsNE42KG2pL3vn NFP3N2U{KHenZXvz M1y4cWFvfGm2dX3vdkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgfIVvd2e{YX\0[YQhcW5iQnHsZk9kKG63ZHWgcY92e2ViYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4heDJzIHX4dJJme3Orb36gZZQhOC53IH3nM4toNCCrcDDh[I1qdmm|dHXy[YQhfGi{ZXWgeIlu\XNiYTD3[YVsKG[xcjD0bJJm\SC5ZXXrd{B{fGG{dHnu[{Bnem:vIHThfUA4KGGodHXyJJR2dW:{IHPlcIwhcW6xY4XsZZRqd25iYomgbY1ufW6xaHnzeI9kcGWvaXPhcEBidg>? MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF7M{KxOkc,OzBzOUOyNVY9N2F-
MCF7 NV\KXFJzSW62aYT1cY9zKGG|c3H5 NYrYfoFxOC53IH3nM4to NWexOZpbOyC5ZXXrdy=> NV\CcnNKSW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{B5\W6xZ4Lh[pRm\CCrbjDCZYxjN2NiboXk[UBud3W|ZTDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCyMkeg[ZhxemW|c3nvckBifCByLkWgcYcwc2duIHnwJIFldWmwaYP0[ZJm\CC2aILl[UB1cW2nczDhJJdm\WtiZn;yJJRpemWnIIfl[Yt{KHO2YYL0bY5oKG[{b32g[IF6KDdiYX\0[ZIhfHWvb4KgZ4VtdCCrbn;jeYxifGmxbjDifUBqdW23bn;obZN1d2OqZX3pZ4FtKGGw MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF7M{KxOkc,OzBzOUOyNVY9N2F-
MCF7 MoP1RY51cXS3bX;yJIF{e2G7 MVuwMlUhdWdxa3e= MoX0N{B4\WWtcx?= NWrzR4FZSW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{B5\W6xZ4Lh[pRm\CCrbjDCZYxjN2NiboXk[UBud3W|ZTDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5idIXtc5Ih\3Kxd4ToJIF1KDBwNTDt[{9s\yxiaYCgZYRucW6rc4TldoVlKHSqcnXlJJRqdWW|IHGge4VmcyCob4KgeIhz\WVid3Xlb5Mhe3SjcoTpcoch\nKxbTDkZZkhPyCjZoTldkB1fW2xcjDj[YxtKGmwb3P1cIF1cW:w MkXVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzOUOyNVYoRjNyMUmzNlE3RC:jPh?=
MCF7 NFe5fppCdnSrdIXtc5Ih[XO|YYm= M4rvc|AvPSCvZz;r[y=> MmriN{B4\WWtcx?= Mnf0RY51cXS3bX;yJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczD4[Y5w\3KjZoTl[EBqdiCEYXziM4MhdnWmZTDtc5V{\SCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBD[XhiZYjwdoV{e2mxbjDheEAxNjVibXevb4ctKGmyIHHkcYlvcXO2ZYLl[EB1cHKnZTD0bY1meyCjIIfl[Ysh\m:{IITodoVmKHenZXvzJJN1[XK2aX7nJIZzd21iZHH5JFch[W[2ZYKgeJVud3JiY3XscEBqdm:ldXzheIlwdiCkeTDpcY12dm:qaYP0c4Np\W2rY3HsJIFv M1TZN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMUmzNlE3Lz5|MEG5N|IyPjxxYU6=
C3H10T1/2 NWXq[GZ7TnWwY4Tpc44h[XO|YYm= NGrUTpoxNjVidV2= MU[yOEBpenN? NI\zXmlC[3SrdnH0bY9vKG:oIHjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJI5wdi22YYLn[ZRqdmdic3nSUmEhfHKnYYTl[EBud3W|ZTDDN2gyOFRzL{KgZ4VtdHNiYYPz[ZN{\WRiYYOg[YZn\WO2IH;uJHZFWiCneIDy[ZN{cW:wIHH0JFAvPSC3TTDh[pRmeiB{NDDodpMh[nlicWDDVkBidmGueYPpdy=> NGH6NmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEezNFk5PCd-MkS3N|A6QDR:L3G+
C3H10T1/2 MoTiSpVv[3Srb36gZZN{[Xl? NVzG[nFwOC53IIXN Mn[5NlQhcHK| NUCxUFlCSWO2aY\heIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeTDpckBXTFJva37vZ4tld3ewIH3veZNmKEN|SEGwWFEwOiClZXzsd{Bie3Onc4Pl[EBieyCnZn\lZ5Qhd25iVlTSJIV5eHKnc4Ppc44h[XRiMD61JJVOKGGodHXyJFI1KGi{czDifUByWEOUIHHuZYx6e2m| NV[4OVJKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3N|A6QDRpPkK0O|MxQTh2PD;hQi=>
C3H10T1/2 MlTtSpVv[3Srb36gZZN{[Xl? MofwNE42KHWP MXqyOEBpenN? MUfF[oZm[3Rib36gR3lROjSDMTDSUmEhdGW4ZXygbY4hdm:wLYThdodmfGmwZzDzbXJPSSC2cnXheIVlKG2xdYPlJGM{UDFyVEGvNkBk\WyuczDheEAxNjVidV2gZYZ1\XJiMkSgbJJ{KGK7IIHQR3Ih[W6jbInzbZM> Ml7oQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5M{C5PFQoRjJ2N{OwPVg1RC:jPh?=
C3H10T1/2 NF;rfFVHfW6ldHnvckBie3OjeR?= NIDjUo8xNjVidV2= Mm\MNlQhcHK| M3jF[2lvcGmkaYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XliaX6gco9vNXSjcnfleIlv\yC|aWLORUB1emWjdHXkJI1wfXOnIFOzTFExXDFxMjDj[YxteyCjc4Pld5Nm\CCjczDl[oZm[3Rib36gWmRTKGW6cILld5Nqd25iYYSgNE42KHWPIHHmeIVzKDJ2IHjyd{BjgSCzUFPSJIFv[Wy7c3nz NGXOTm49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEezNFk5PCd-MkS3N|A6QDR:L3G+
C3H10T1/2 M2rZWGZ2dmO2aX;uJIF{e2G7 MWCwMlUhfU1? M3LlTVI1KGi{cx?= MYfJcohq[mm2aX;uJI9nKGinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGmwIG\EVk1sdm:la3Tve44hdW:3c3WgR|NJOTCWMT:yJINmdGy|IHHzd4V{e2WmIHHzJIVn\mWldDDvckBXTFJiZYjwdoV{e2mxbjDheEAxNjVidV2gZYZ1\XJiMkSgbJJ{KGK7IIHQR3Ih[W6jbInzbZM> M2HjblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{OwPVg1Lz5{NEezNFk5PDxxYU6=
LX2 NXLtPZVCTnWwY4Tpc44h[XO|YYm= M{O3SlExOCCwTR?= MlO0NlQhcHK| NIfmfGFVemGwc3HjeIl3[XSrb36gc4YhXkSUIHnuJIh2dWGwIFzYNkBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIGTHSoJmfGFzLXnu[JVk\WRiQ1;MNWEyKG2UTlGg[ZhxemW|c3nvckBifCBzMECgcm0h[W[2ZYKgNlQhcHK|IHL5JHEuWEOUIHHuZYx6e2m| NXrXeooxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CzOVA6QTlpPkOwN|UxQTl7PD;hQi=>
ROS 17/2.8 NGLCVlBHfW6ldHnvckBie3OjeR?= M{HvPVE3KGi{cx?= M1rHXGlv\HWldHnvckBw\iCYRGKgeJJidnOlcnnweIlwdmGuIHHjeIl3cXS7IHHzd4V{e2WmIHHzJIFkfGm4YYTpc44hd2ZiMkStbJllem:6eXzhd4Uh\2WwZTDlfJBz\XO|aX;uJIlvKHKjdDDSU3MhOTdxMj64JINmdGy|IHHmeIVzKDF4IHjyd{BjgSCudXPp[oVz[XOnIILldJJ1\XJiYYPzZZk> MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjV5NEmyNUc,OjZ3N{S5NlE9N2F-
HL60 NUf4RpVRTnWwY4Tpc44h[XO|YYm= M1PvSVMxKHSxIEGwNFAhdk1? NIfpd2E1QCCqcoO= M1G4N2lv\HWldHnvckBw\iClZXzsJIRq\m[ncnXueIlifGmxbjDpckBpfW2jbjDIUFYxKGOnbHzzJIF{e2W|c3XkJIF{KG2jdIXybY5oKG2xcoDoc4xw\2mlYXygZ4hidmenczDheEA{OCC2bzCxNFAxKG6PIHHmeIVzKDR6IHjyd{BjgSCZcnnnbJQoey2JaXXtd4Ehe3SjaX7pcocu[mG|ZXSg[o9zfHlibXnjdo9{[2:yaXOgeolmfyCjc4PhfS=> MmTIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzMkexOFkoRjJ3MUK3NVQ6RC:jPh?=
SW480-ADH NHvnWXJHfW6ldHnvckBie3OjeR?= M2fXWVExOCCwTR?= M4HadVQ5KGi{cx?= NXnLUGVbUW6mdXP0bY9vKG:oIHj1cYFvKFOZNEiwMWFFUCClZXzsJIRq\m[ncnXueIlifGmxbjDhd5Nme3OnZDDhd{Bnd3KvYYTpc44hd2ZiY3;tdIFkfCCncHn0bIVtcW:rZDDpd4xidmS|IH;mJIhq\2iueTDh[IhmemWwdDDj[YxteyCjdDCxNEAoNTdiTTDh[pRmeiB2ODDodpMh[nlicHjhd4Uu[2:wdILhd5QhdWmlcn;zZ49xgQ>? NX7iRY9DRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK5PFk{PzlpPkKyPVg6Ozd7PD;hQi=>
SW480-ADH MmTPSpVv[3Srb36gZZN{[Xl? NVTRcYFYOTBibl2= M2rZdlQ5KGi{cx?= MoOzTY5lfWO2aX;uJI9nKGi3bXHuJHNYPDhyLVHETEBk\WyuIHTp[oZmemWwdHnheIlwdiCjc4Pld5Nm\CCjczDmc5Ju[XSrb36gc4Yh[2:vcHHjeEBmeGm2aHXsbY9q\CCrc3zhcoR{KG:oIHjp[4htgSCjZHjldoVvfCClZXzsd{BifCBzMDCnMVghVSCjZoTldkA1QCCqcoOgZpkheGijc3WtZ49vfHKjc4SgcYlkem:|Y3;wfS=> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl6OUO3PUc,OjJ7OEmzO|k9N2F-
MCF7 NXXlUXRpSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MkTjNVAxKG6P M4rF[VQ5KGi{cx?= MnLWRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3JINmdGy|IHH0JFExKCdvNzDNJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmgdoVt[XSrdnWgeI8hfW62cnXheIVlNWOxboTyc4w> MmDJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7OEmzO|koRjJ{OUi5N|c6RC:jPh?=
CLL MUPGeY5kfGmxbjDhd5NigQ>? MYqxNFAhdk1? NVW2SJZbOjRiaILz M4D3NGVn\mWldDDvckBEYVB{NFGxJIlvKGi3bXHuJJBzcW2jcomgR2xNKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIG\EVk1z\We3bHH0[YQhT0GGRES1ZYxxcGFibWLORUBmgHC{ZYPzbY9vKGG2IEGwNEBvVSCrbnP1ZoF1\WRiZn;yJFI1KGi{czDifUByfWGwdHn0ZZRqfmViUmStVGNTKG2ndHjv[C=> M32zWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS4N|kzLz5{NUG0PFM6OjxxYU6=
CLL NFqzfY9HfW6ldHnvckBie3OjeR?= MkOxNVAxKG6P NV\M[JlKOjRiaILz MX\F[oZm[3Rib36gR3lROjSDMTDpckBpfW2jbjDwdolu[XK7IFPMUEBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCYRGKtdoVofWyjdHXkJGNFU05zQTDtVm5CKGW6cILld5Nqd25iYYSgNVAxKG6PIHnuZ5Vj[XSnZDDmc5IhOjRiaILzJIJ6KHG3YX70bZRifGm4ZTDSWE1RS1JibXX0bI9l NHLKclE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0PFM6Oid-MkWxOFg{QTJ:L3G+

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
CyclinD1 ; 

PubMed: 28643892     


Immunoblot analysis of cyclinD1 in AXT cells treated with the indicated concentrations of calcitriol for 14 h. 

IRE1α / p-eIF2α / eIF2α / Atf4 / CHOP ; 

PubMed: 28643892     


Immunoblot analysis of Ire1a and total or phosphorylated (p-) forms of eIf2a, Atf4 and Chop in AXT cells treated with 5 lM calcitriol for the indicated times.

p-PERK / PERK ; 

PubMed: 28643892     


Immunoblot analysis of total or phosphorylated (p-) forms of Perk and Atf4 in AXT cells treated with 5 lM calcitriol for the indicated times or with 1 lM thapsigardin (Thap) for 1.5 h.

FGFR1 / FGFR2 / FGFR3 / FGFR4 ; 

PubMed: 29776409     


Representative immunoblots and average data (n = 6) of FGFR1, FGFR2, FGFR3, and FGFR4 from control and calcitriol (1 and 10 nM)-treated HL-1 cells.

Wnt10b / Wnt16 ; 

PubMed: 30149605     


Wnt10b and Wnt 16 protein expression in calcitriol-treated osteoclasts. With calcitriol treatment of 10 to 100 nM overnight, Western blot analysis showed a significant increase in Wnt 10b expression. Wnt 16 expression in osteoclasts after different doses of calcitriol was not significantly different at the protein level. Actin protein served as a loading control. 

28643892 29776409 30149605

Protocol

Solubility (25°C)

In vitro DMSO 83 mg/mL (199.21 mM)
Water Insoluble
Ethanol '''83 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 416.64
Formula

C27H44O3

CAS No. 32222-06-3
Storage 3 years -20°C powder
Synonyms Topitriol, 1,25-Dihydroxyvitamin D3
Smiles CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04551170 Recruiting Drug: Theophylline|Drug: Placebo Pseudohypoparathyroidism|Albright Hereditary Osteodystrophy|Pseudohypoparathyroidism Type 1a Vanderbilt University Medical Center July 13 2020 Phase 2
NCT03029429 Recruiting Drug: Theophylline|Drug: Placebos Pseudohypoparathyroidism|Albright Hereditary Osteodystrophy Vanderbilt University Medical Center|Harvard University September 1 2018 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Calcitriol (RO215535) | Calcitriol (RO215535) ic50 | Calcitriol (RO215535) price | Calcitriol (RO215535) cost | Calcitriol (RO215535) solubility dmso | Calcitriol (RO215535) purchase | Calcitriol (RO215535) manufacturer | Calcitriol (RO215535) research buy | Calcitriol (RO215535) order | Calcitriol (RO215535) mouse | Calcitriol (RO215535) chemical structure | Calcitriol (RO215535) mw | Calcitriol (RO215535) molecular weight | Calcitriol (RO215535) datasheet | Calcitriol (RO215535) supplier | Calcitriol (RO215535) in vitro | Calcitriol (RO215535) cell line | Calcitriol (RO215535) concentration | Calcitriol (RO215535) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID